Countries North America

WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma

       WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced that the U.S. Food and Dr...

 February 21, 2024 | News

Gilead Sciences Bolsters Liver Portfolio Through Acquisition of CymaBay Therapeutics

    Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced today a definitive agreement whereby Gilead will acquire CymaBay for $32.50 ...

 February 13, 2024 | News

AstraZeneca Boosts US Manufacturing to Accelerate Cell Therapy Advancements

AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell therapy platforms in the US for critic...

 February 07, 2024 | News

Genesis MedTech Finishes U.S. Study Enrollment for J-Valve™ in Severe Aortic Regurgitation

Genesis MedTech, a leading medical device company, today announced the completion of enrollment in its United States Early Feasibility Study (EFS) usi...

 February 06, 2024 | News

LabCorp Launches New Test for Severe Preeclampsia Risk in Pregnant Women

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services,  announced the launch and availability of a new, FDA-cle...

 February 01, 2024 | News

Amcor Expands Thermoforming Capacity for Healthcare Growth in North America

The addition of automated, state-of-the art thermoforming equipment at Amcor's world-class healthcare manufacturing plant in Oshkosh, Wisconsin w...

 February 01, 2024 | News

Allied Digestive Health and Provation Sign Agreement for Enhanced Patient Care

Allied Digestive Health (ADH), the beacon of cutting-edge gastroenterology (GI) services across New Jersey and New York, is joining forces with Provation, ...

 January 22, 2024 | News

Bora Pharmaceuticals Expands Globally with $210 Million Acquisition of Upsher-Smith

BioPharma APAC Perspective: Bora's acquisition of Upsher-Smith for $210 million marks a pivotal moment for the pharmaceutical giant. This strategic move n...

 January 18, 2024 | News

OBI Pharma's partner Biosion announces FDA clearance for the Phase 1/2 study of OBI-992 (TROP2 ADC)

First clinical trial to evaluate the safety and efficacy of OBI-992 (a.k.a BSI-992), a novel antibody drug conjugate (ADC) targeting TROP2 - Dosing of f...

 January 09, 2024 | News

Biocon Biologics Successfully Integrates Acquired Biosimilars Business Across 120 Countries

Biocon Biologics, a unique, fully integrated, global biosimilars company with a rich portfolio of insulins and monoclonal antibodies, has successfully conc...

 December 19, 2023 | News

First Patient Dosed in U.S. Access Program for Telix's TLX250-CDx Kidney Cancer Imaging

The patient was dosed at ARA Diagnostic Imaging at Austin Radiological Association in Austin (TX, U.S.) following U.S. Food and Drug Administrati...

 December 12, 2023 | News

Sirio Pharma and Best Formulations Announce U.S. Gummy Manufacturing Capabilities

Sirio Pharma Co., Ltd. (Sirio), a leading global CDMO, is pleased to announce the addition of new gummy manufacturing capabilities at its Best Formulations...

 October 20, 2023 | News

Suvoda Enhances IRT for Precise Clinical Trial Drug Supply

 Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system...

 October 12, 2023 | News

Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing

Headquartered in Beijing, China, Sino Biological is the world’s leading provider of mammalian cell-based recombinant proteins, antibodies, and relate...

 October 10, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close